| 查看: 774 | 回复: 0 | |||
[交流]
资深新药研发专家Stephenson博士正式加入苏州晶云药物科技有限公司
|
|
晶彩导读 2017年2月10日，苏州晶云药物科技有限公司荣幸地宣布新药研发领域专家Gregory A. Stephenson 博士正式加入晶云，担任高级科学顾问。Stephenson博士将与晶云研发团队携手，为全球创新药公司提供始终领先的药物固态性质研究及CMC研发服务。 CRYSTAL PHARMATECH EXPANDS LEADERSHIP TEAM Crystal Pharmatech is honored to announce it has expanded its’ leadership team to include Dr. Gregory A. Stephenson. This reflects Crystal Pharmatech’s continued strategy to ensure the management team keeps pace with the company’s expansion. As Senior Scientific Advisor, Dr. Stephenson will report directly to the Vice President of Business Development, Dr. Robert Wenslow, and work closely with the research and development team to ensure clients are offered the highest level of service in the industry. Before joining Crystal Pharmatech, Dr. Stephenson spent 27 years at Eli Lilly and Co. His tenure involved close interactions with discovery teams during lead optimization, development process chemists, and formulators with a primary objective of early selection of the physical form that provided optimal balance of physical properties to ensure adequate exposure, chemical and physical stability, and processing characteristics for its product’s dosage form. “Greg is exactly the type of individual we want on our leadership team. He combines unmatched expertise in solid-state chemistry with practical cross-functional experience of leading successful development programs” explains Dr. Alex M. Chen, CEO of Crystal Pharmatech Co., Ltd. “As we expand, we need to maintain a high level of practical development experience to ensure our customer needs are met. Staying on top of innovation while focusing on applied problem solving will continue to ensure Crystal Pharmatech remains the leading technology-driven CRO.” Founded in July 2010, Crystal Pharmatech is a global，technology-driven research organization with labs in China and the US with combined over 65,000 sq. ft. and over 100 employees. Our research focuses on form screening/selection, crystallization development and add-on CMC services that guide pharmaceutical companies to develop new drugs efficiently and effectively. With a leading platform in solid form research, Crystal Pharmatech has built successful business relationships with over 200 pharmaceutical companies with a primary focus of progressing compounds from candidate selection to IND application. |
![\"资深新药研发专家Stephenson博士正式加入苏州晶云药物科技有限公司\"](\"https://muchongimg.xmcimg.com/data/bcs/2017/0211/bw178h673617_1486744525_576.jpg#opennewwindow\")
回复此楼» 猜你喜欢
求26届aidd博导推荐
已经有4人回复
-
2026申博推荐
已经有1人回复
-
药理学论文润色/翻译怎么收费?
已经有103人回复
-
一篇扩散模型的Nature Machine Intelligence论文和Elsevier上的深度学习药物书籍
已经有1人回复
-
中国药科大学2026入学博士，药物合成和设计经验，放射化学及放射医学研究
已经有25人回复
-
使用MolAICal进行多肽虚拟筛选教程-同样适用于蛋白质和核酸的虚拟筛选
已经有1人回复
-
使用MolAICal计算药物化学过滤器MCFs及MCE-18描述符
已经有0人回复
-
使用MolAICal发现蛋白受体潜在的活性口袋及位点
已经有0人回复